Improved detection and measurement of low levels of [ 18F]fluoride metabolized from [ 18F]-labeled pyrimidine nucleoside analogues in biological samples

Nuclear Medicine and Biology

Volumn 38, Issue 8, 2011, Pages 1129-1134

  Paolillo, Vincenzo ^a   Yeh, Hsin Hsien ^a   Mukhopadhyay, Uday ^a   Gelovani, Juri G ^a   Alauddin, Mian M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

18F Fluoride; Ion exchange cartridge; PET; Radiopharmaceuticals

Indexed keywords

FEAU F 18; FLT F 18; FLUORINE 18; FMAU F 18; FPRT F 18; PYRIMIDINE NUCLEOSIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG SYNTHESIS; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ION EXCHANGE; MOUSE; NONHUMAN; RADIOACTIVITY; SENSITIVITY ANALYSIS;

ANIMALS; BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORIDES; FLUORINE RADIOISOTOPES; ION EXCHANGE; MICE; SENSITIVITY AND SPECIFICITY; URINE;

EID: 82655172516     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2011.05.008     Document Type: Article

References (21)

1. Rosé C., Dose J., Avril N. Positron emission tomography for the diagnosis of breast cancer. Nucl Med Comm 2002, 37:613-618.
2. 18F-FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors. Clin Cancer Res 2002, 8:3315-3323.
3. 18F]FEAU. Nat Protoc 2007, 2:416-423.
4. 6-IPQA. PNAS 2002, 108(4):1603-1608.
5. 18F]-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma. J Nucl Med 2003, 44:224-239.
6. Ikenish R., Kitarawa T., Nishiuchi M. Gas chromatographic method for the determination of fluoride ion in biological samples: I. Fluoride level in monkey. Chem Pharm Bull 1988, 36:662-669.
7. Ikenishi R., Kitagawa T. Gas chromatographic method for the determination of fluoride ion in biological samples: II. Stability of fluorine-containing drugs and compounds in human plasma. Chem Pharm Bull 1988, 36:810-814.
8. 11C]flumazenil in human: assessment as the standardized value for quantitative PET studies. Anals Nucl Med 1998, 12:55-59.
9. 11C]methionine in human plasma. Eur J Nucl Med 1989, 15:655-669.
10. 11C]pyrilamine. Tokohu J Exp Med 1996, 178:129-136.
11. 18F]FLT. Nucl Med Biol 2002, 29:263-273.
12. 18F]FMAU). J Labelled Comp Radiopharm 2002, 45:583-590.
13. 18F]-labeled 2'-deoxy-2'-fluoro-1-β-d-arabinofuranosyluracil nucleosides. J Labelled Comp Radiopharm 2003, 46:285-290.
14. 18F]fluoropropyl thymidine. Nucl Med Biol 2008, 35:697-705.
15. Currie Lloyd A. Limits for qualitative detection and quantitative determination: application to radiochemistry. Anal Chem 1968, 40:586-593.
16. 18F]-FMAU and PET. J Nucl Med 2005, 46:292-296.
17. 18F-fluoro-β-d-arabinofuranosyl)thymine and PET. J Nucl Med 2007, 48:1436-1441.
18. 18F]FLT and positron emission tomography. Nat Med 1998, 4:1334-1336.
19. 18F-fluorothymidine positron emission tomography imaging: evaluation of analytical methods. Cancer Res 2005, 65:10104-10112.
20. Shields A.F., Grierson J.R., Muzik O., Stayanoff J.C., Lawhorn-Crews J.M., et al. Kinetics of 3-deoxy-3-[F-18]fluorothymidine uptake and retention in dogs. Mol Imag Biol 2002, 4:83-89.
21. 18FLT utilization in colorectal cancer. Eur J Nucl Med Mol Imaging 2004, 31:169-178.